We are live on ! Find out more
BTSG icon

BrightSpring Health Services
BTSG

96 hedge funds and large institutions have $2.23B invested in BrightSpring Health Services in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

10,232% more call options, than puts

Call options by funds: $5.17M | Put options by funds: $50K

144% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 16

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

12% more funds holding

Funds holding: 86 → 96 (+10)

5% more capital invested

Capital invested by funds: $2.12B → $2.23B (+$106M)

0.74% more ownership

Funds ownership: 113.61% → 114.35% (+0.74%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.39%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
39
Reduced
16
Closed
18
Calls
$5.17M
Puts
$50K
Net Calls
+$5.12M
Net Calls Change
+$5.13M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.9M
2
JGC
J. Goldman & Co
New York
+$12.2M
3
Morgan Stanley
Morgan Stanley
New York
+$7.75M
4
Goldman Sachs
Goldman Sachs
New York
+$7.12M
5
Bank of America
Bank of America
North Carolina
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$19.4M
2
SFM
Soros Fund Management
New York
-$12M
3
SSA
Schonfeld Strategic Advisors
New York
-$10.3M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$9.83M
5
Capstone Investment Advisors
Capstone Investment Advisors
New York
-$9.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
101
Marshall Wace
United Kingdom
– -$4.01M -369,224 Closed
DKCM
102
Davidson Kempner Capital Management
New York
– -$2.72M -250,000 Closed
Holocene Advisors
103
Holocene Advisors
New York
– -$2.65M -243,954 Closed
OCM
104
Ovata Capital Management
Hong Kong
– -$2.17M -200,000 Closed
LCM
105
Laurion Capital Management
New York
– -$1.73M -159,388 Closed
Qube Research & Technologies (QRT)
106
Qube Research & Technologies (QRT)
United Kingdom
– -$1.29M -118,884 Closed
SI
107
Symmetry Investments
Jersey
– -$870K -80,000 Closed
Tudor Investment Corp
108
Tudor Investment Corp
Connecticut
– -$624K -57,420 Closed
AIG
109
American International Group
New York
– -$289K -26,581 Closed
SOW
110
State of Wyoming
Wyoming
– -$139K -12,800 Closed
JFG
111
Jefferies Financial Group
New York
– -$109K -10,000 Closed
MLICM
112
Metropolitan Life Insurance Company (MetLife)
New York
– -$32K -2,946 Closed
Osaic Holdings
113
Osaic Holdings
Arizona
– -$24.6K -2,260 Closed
Simplex Trading
114
Simplex Trading
Illinois
– -$1.92K -176 Closed
1 2 3 4
5

BTSG Hedge Fund Activity: Q2 2024 in Review

96 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BrightSpring Health Services (BTSG) for Q2 2024, worth a combined $2.23B — up 5% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BTSG positions and 18 closed out — a net gain of 11 holders — while 39 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $45.9M. The largest seller was Citadel Advisors, cutting an estimated $19.4M.

  • 96 institutional investors held BrightSpring Health Services (BTSG) as of Q2 2024, up from 86 in Q1 2024.
  • Funds reported $2.23B of BrightSpring Health Services stock for Q2 2024, up 5% quarter-over-quarter.
  • 29 funds opened new BrightSpring Health Services positions in Q2 2024 and 18 closed out, a net change of +11 holders.
  • The largest BrightSpring Health Services buyer in Q2 2024 was Fidelity Investments, an estimated $45.9M added.
  • The largest BrightSpring Health Services seller in Q2 2024 was Citadel Advisors, an estimated $19.4M sold.

Based on aggregated 13F filings for Q2 2024.